The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Sep 06, 2026
Snapshot (as of Sep 06, 2026): Vanguard PRIMECAP Fund Investor Shares (VPMCX) pays a $29.21 annual dividend, yielding 13.10% at $222.93/share. Next ex-dividend date 2025-12-17. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 13.10%
Annual Dividend: $29.21 per share
Ex-Dividend Date: 2025-12-17
Sector: Financial Services
Years of Dividend History: 41
The Vanguard PRIMECAP Fund Investor Shares dividend currently yields 13.1%, making it one of the higher-yielding fund options available to income-focused investors. VPMCX is a growth-oriented fund managed by PRIMECAP Management Company, investing primarily in large and mid-sized companies with a long-term outlook and exceptionally low portfolio turnover. The trailing annual dividend rate stands at $29.2065 per share, with the next ex-dividend date set for December 17, 2025. A beta of 1.046 means the fund moves roughly in line with the broader market, which suits dividend investors who can tolerate moderate price swings in exchange for a high current payout.
Vanguard PRIMECAP Fund Investor Shares pays out dividends as a fund, making the payout ratio not applicable (fund/ETF). Vanguard PRIMECAP Fund Investor Shares dividend safety is therefore not assessed through a traditional earnings-coverage lens; instead, the payout level reflects the fund's underlying portfolio distributions, which are shaped by the multi-manager structure PRIMECAP employs across independently run portfolio segments. The most significant pressure point is the fund's concentration in technology and health care, two sectors that can produce sharp short-term swings in income and capital gains distributions.
Vanguard PRIMECAP Fund Investor Shares dividend history shows a CAGR of 12.1% per year from 2008 to 2025. Per-share payments grew from $4.1700 in 2008 to $29.2065 in 2025, a substantial absolute gain over the window. The largest annual increase in the window was 174.5% in 2025, which is an outlier that skews the overall picture. The data also contains at least one year-over-year decline exceeding 5%, so growth has not been linear.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +32.9% | $12.44 (2022) | $29.21 (2025) |
| 5-Year | +15.1% | $14.46 (2020) | $29.21 (2025) |
| 10-Year | +17.4% | $5.89 (2015) | $29.21 (2025) |
VPMCX fits dividend investors who prioritize a high current payout over predictable, steady annual increases. The yield is classified as high (above 4%), and at 13.1% it sits well above the fund's own 5-year average of 7.14%, which reflects the outsized 2025 distribution rather than a structural shift in the fund's income profile. The fund's concentration in technology and health care means distributions can swing sharply from year to year, as the history table confirms. What an investor gets here is a high nominal yield backed by a long-running, low-turnover growth fund; what they accept is meaningful year-to-year variability in the actual dollar amount paid.
| Payment Date | Amount per Share |
|---|---|
| 2025-12-17 | $29.2065 |
| 2024-12-18 | $10.6389 |
| 2023-12-19 | $10.8076 |
| 2022-12-19 | $12.4385 |
| 2021-12-20 | $16.4863 |
| 2020-12-21 | $14.4569 |
| 2019-12-17 | $9.9520 |
| 2018-12-18 | $9.7100 |
| 2017-12-18 | $7.2330 |
| 2016-12-23 | $5.3030 |
| Year | Total Dividends |
|---|---|
| 2025 | $29.2065 |
| 2024 | $10.6389 |
| 2023 | $10.8076 |
| 2022 | $12.4385 |
| 2021 | $16.4863 |
Project income from VPMCX with the VPMCX dividend calculator or track your full portfolio with the dividend tracker.